• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

REGENXBIO Inc.

REGENXBIO Inc.

Public
RGX
United States
SectorHealthcare
CountryUnited States
Market cap467.65M
A clinical-stage gene therapy company developing one-time curative treatments for rare diseases.

Where to buy REGENXBIO Inc. (RGX)

RGX trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare